About
Neovacs develops mRNA and LNP technology platforms to create treatments for chronic inflammatory diseases, focusing on products for asthma, food allergies, and lupus. It also offers its mRNA/LNP development expertise through external partnerships for new therapeutic targets.
Explore Neovacs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.